Denis Schewe

14PUBLICATIONS
49CO-AUTHORS
Infant and child healthHaematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|May 27, 2026
Safety of Telemedicine Follow-Up Visits in Children With Cancer Undergoing Intensive Chemotherapy: Results From the Randomized KULT-SH Trial.

|Oct 20, 2025
Cell cycle regulator MYBL2 is a distinct vulnerability in acute myeloid leukemia.

Sandra Küchler, Silke Brilloff, Silvia Schäfer

|Mar 22, 2024
The IL-7R antagonist lusvertikimab reduces leukemic burden in xenograft ALL via antibody-dependent cellular phagocytosis.

Lennart Lenk, Irène Baccelli, Anna Laqua

|Nov 21, 2022
Isocitrate dehydrogenase 1 mutation drives leukemogenesis by PDGFRA activation due to insulator disruption in acute myeloid leukemia (AML).

Sophie Steinhäuser, Patricia Silva, Lennart Lenk

|Nov 27, 2021
Transcriptional and Mutational Profiling of B-Other Acute Lymphoblastic Leukemia for Improved Diagnostics.

Philippe Chouvarine, Željko Antić, Jana Lentes

|Sep 28, 2021
In vivo inducible reverse genetics in patients' tumors to identify individual therapeutic targets.

Michela Carlet, Kerstin Völse, Jenny Vergalli

Pageof 3

Frequent Collaborators

3 joint publications

Lennart Lenk

3 joint publications

Irmela Jeremias

3 joint publications

Željko Antić

2 joint publications

Anke K Bergmann